共 40 条
[1]
ABERLE H, 1994, J CELL SCI, V107, P3655
[2]
ABRAHAMSON JLA, 1995, MOL CELL BIOL, V15, P6953
[7]
Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2001, 19 (05)
:1405-1413
[8]
de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847